Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Annerberg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|November 24, 2005
Pitfalls in estimating piperaquine eliminationJoel Tarning, Niklas Lindegårdh, Anna Annerberg, et al.
Tropical Medicine & International Health : TM & IH|February 16, 2007
How much fat is necessary to optimize lumefantrine oral bioavailability?Elizabeth A Ashley, Kasia Stepniewska, Niklas Lindegårdh, et al.
Antimicrobial Agents and Chemotherapy|January 23, 2014
Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malariaJoel Tarning, Niklas Lindegardh, Khin Maung Lwin, et al.
European Journal of Clinical Pharmacology|March 20, 2010
Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malariaElizabeth A Ashley, Kasia Stepniewska, Niklas Lindegardh, et al.
Tropical Medicine & International Health : TM & IH|February 23, 2008
Plasmodium vivax resistance to chloroquine in Dawei, southern MyanmarJean-Paul Guthmann, Anne Pittet, Alexandre Lesage, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2010
Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in TanzaniaSofia Friberg Hietala, Andreas Mårtensson, Billy Ngasala, et al.
Tropical Medicine & International Health : TM & IH|November 19, 2004
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic RepublicJörg M Stohrer, Sabine Dittrich, Vonthalom Thongpaseuth, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
A small amount of fat does not affect piperaquine exposure in patients with malariaAnna Annerberg, Khin Maung Lwin, Niklas Lindegardh, et al.
Tropical Medicine & International Health : TM & IH|December 21, 2006
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest CambodiaMey Bouth Denis, Reiko Tsuyuoka, Pharath Lim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2004
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic RepublicMayfong Mayxay, Maniphone Khanthavong, Niklas Lindegårdh, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|November 24, 2005
Pitfalls in estimating piperaquine eliminationJoel Tarning, Niklas Lindegårdh, Anna Annerberg, et al.
Tropical Medicine & International Health : TM & IH|February 16, 2007
How much fat is necessary to optimize lumefantrine oral bioavailability?Elizabeth A Ashley, Kasia Stepniewska, Niklas Lindegårdh, et al.
Antimicrobial Agents and Chemotherapy|January 23, 2014
Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malariaJoel Tarning, Niklas Lindegardh, Khin Maung Lwin, et al.
European Journal of Clinical Pharmacology|March 20, 2010
Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malariaElizabeth A Ashley, Kasia Stepniewska, Niklas Lindegardh, et al.
Tropical Medicine & International Health : TM & IH|February 23, 2008
Plasmodium vivax resistance to chloroquine in Dawei, southern MyanmarJean-Paul Guthmann, Anne Pittet, Alexandre Lesage, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2010
Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in TanzaniaSofia Friberg Hietala, Andreas Mårtensson, Billy Ngasala, et al.
Tropical Medicine & International Health : TM & IH|November 19, 2004
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic RepublicJörg M Stohrer, Sabine Dittrich, Vonthalom Thongpaseuth, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
A small amount of fat does not affect piperaquine exposure in patients with malariaAnna Annerberg, Khin Maung Lwin, Niklas Lindegardh, et al.
Tropical Medicine & International Health : TM & IH|December 21, 2006
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest CambodiaMey Bouth Denis, Reiko Tsuyuoka, Pharath Lim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2004
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic RepublicMayfong Mayxay, Maniphone Khanthavong, Niklas Lindegårdh, et al.
Pageof 2